Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

R&D Expenses

$61.20M

Quarterly · Period ending: · USD

BIO logo

BIO R&D Expenses

Latest reported$61.20M
BIO Quarterly R&D Expenses ($0.00 → $61.20M)
High-resolution chart · PNG

BIO r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
17,701,000
18,428,000
16,517,000
16,372,000
17,380,000
17,871,000
18,800,000
11,000,000
10,900,000
10,500,000
10,600,000
10,200,000
10,600,000
9,900,000
13,100,000
11,000,000
11,200,000
10,800,000
10,600,000
9,700,000
9,600,000
9,600,000
9,300,000
8,500,000
8,500,000
8,400,000
8,300,000
7,300,000
7,300,000
7,300,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.